Drug Profile
Anti-interleukin-2 receptor monoclonal antibody ART-18
Alternative Names: Anti-CD25 monoclonal antibody ART-18; ART-18; Interleukin-2 receptor monoclonal antibody ART-18Latest Information Update: 06 Aug 1998
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action Interleukin 2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 06 Aug 1998 No-Development-Reported for Transplant rejection in Germany (Unknown route)
- 20 Mar 1996 New profile
- 20 Mar 1996 Preclinical development for Transplant rejection in Germany (Unknown route)